Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Sweden
  4. Nasdaq Stockholm
  5. Getinge AB
  6. News
  7. Summary
    GETI B   SE0000202624

GETINGE AB

(GETI B)
  Report
Delayed Nasdaq Stockholm  -  11:29 2022-10-06 am EDT
194.05 SEK   +0.65%
10/04Getinge Announces Its Q3 Report 2022 On October 19 At 08 : 00 CEST followed by a conference call at 10:00 CEST
AQ
09/23Getinge appoints Joanna Engelke as new Executive Vice President Quality Compliance, Regulatory & Medical Affairs and member of the Getinge Executive Team
AQ
09/23Getinge AB Appoints Joanna Engelke as New Executive Vice President Quality Compliance, Regulatory & Medical Affairs and Member of the Getinge Executive Team
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Getinge AB Announces Medical Device Field Action of Hls Set Advanced Products

07/20/2022 | 02:40am EDT

Getinge announced an expansion of its voluntary global medical device field action for the HLS Set Advanced products due to a potential breach in sterile packaging. Getinge has reported this field action to relevant authorities according to applicable regulations. To date, there are no known adverse events associated with illness or injuries related to the mentioned issue.

The HLS Set Advanced is used for extracorporeal respiratory and/or cardiovascular support. Getinge has identified that a limited number of HLS Set Advanced products delivered worldwide could have a damaged sterile packaging. To mitigate potential breaches in the sterile packaging a field safety corrective action has been introduced.

All affected customers received communication from Getinge regarding this field action according to local regulations. Pending on the HLS Set Advanced version, instructions may vary for customers.


© S&P Capital IQ 2022
All news about GETINGE AB
10/04Getinge Announces Its Q3 Report 2022 : 00 CEST followed by a conference call at 10:00 CEST
AQ
09/23Getinge appoints Joanna Engelke as new Executive Vice President Quality Compliance, Reg..
AQ
09/23Getinge AB Appoints Joanna Engelke as New Executive Vice President Quality Compliance, ..
CI
09/23GETINGE AB : Changes in management and corporate officers
CO
09/20Swedish Medical Technology Group Getinge To Manufacture Balloon-expandable Covered Sten..
MT
09/20Getinge : partners with Medtronic for the manufacturing of the Radiant balloon-expandable ..
PU
09/15Getinge : Today Agneta Palmér joins Getinge's executive team
PU
08/18Semcon, Getinge Enter Three-Year Deal on Technical Consulting Services in Life Science
MT
08/18Semcon wins framework agreement with Getinge
AQ
07/20Getinge is announcing a medical device field action of HLS Set Advanced products
AQ
More news
Analyst Recommendations on GETINGE AB
More recommendations
Financials
Sales 2022 28 498 M 2 590 M 2 590 M
Net income 2022 3 017 M 274 M 274 M
Net Debt 2022 2 336 M 212 M 212 M
P/E ratio 2022 17,4x
Yield 2022 2,15%
Capitalization 52 513 M 4 772 M 4 772 M
EV / Sales 2022 1,92x
EV / Sales 2023 1,74x
Nbr of Employees 10 986
Free-Float 80,0%
Chart GETINGE AB
Duration : Period :
Getinge AB Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GETINGE AB
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 8
Last Close Price 192,80 SEK
Average target price 292,50 SEK
Spread / Average Target 51,7%
EPS Revisions
Managers and Directors
Mattias Sven Perjos President, Chief Executive Officer & Director
Lars Sandström Chief Financial Officer
Johan Malmquist Chairman
Anna Romberg Executive VP-Legal, Compliance & Governance
Johan Bygge Independent Director
Sector and Competitors
1st jan.Capi. (M$)
GETINGE AB-51.20%4 772
SHOCKWAVE MEDICAL, INC.59.93%10 246
NOVOCURE LIMITED13.16%8 899
MASIMO CORPORATION-50.13%7 669
PENUMBRA, INC.-31.70%7 435
ASAHI INTECC CO., LTD.3.28%4 787